Lenotac (Piroxicam)

Piroxicam blocks the activity of both COX‑1 and COX‑2 enzymes, which are required for prostaglandin production. By reducing prostaglandin levels in the treated tissue, it diminishes the inflammatory response, leading to less pain, swelling and redness at the site of application.

The amount of Lenotac to apply and the frequency of application are set by the prescribing healthcare professional based on the severity of the condition, the size of the treatment area and individual patient factors. No standard dosing regimen is provided here.

Safety data for topical piroxicam in pregnancy and lactation are limited. Healthcare providers usually weigh potential benefits against possible risks before prescribing. Patients who are pregnant, planning pregnancy or breastfeeding should discuss use with their physician.

To request Lenotac, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lenotac contains piroxicam, which has a relatively long half‑life among topical NSAIDs, allowing sustained prostaglandin inhibition. Compared with agents such as diclofenac or ibuprofen gels, piroxicam may offer prolonged anti‑inflammatory effects, but individual response and tolerability can vary, so choice should be guided by clinical judgment.

Lenotac should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, heat and direct sunlight. Do not freeze the product, and keep it out of reach of children.

The prescribed amount of Lenotac is spread thinly over the clean, dry skin of the affected area and gently massaged until absorbed. It should not be applied to broken, infected or excessively hairy skin unless directed by a clinician. Hands should be washed after application.

Serious adverse events, although rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, extensive skin ulceration, systemic NSAID toxicity affecting kidney or liver function, and significant bleeding when combined with anticoagulants.

Lenotac should be avoided in individuals with known hypersensitivity to piroxicam or any NSAID, in patients with active skin infections or open wounds at the intended site, and in those taking systemic NSAIDs, anticoagulants or corticosteroids without medical supervision. Pregnant or breastfeeding women should consult a physician before use.